Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ADCT — ADC Therapeutics SA

CIK 72971 SAN FRANCISCO, CA
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$328,644
-$656,792 QoQ
Shares Held
307,144
+16.9% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 113 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. ADCT ranks #36 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in ADCT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $328,644 307,144
2026-03-31 $985,436 262,783
2025-12-31 $1,129,769 320,048
2025-09-30 $278,004 69,501
2025-06-30 $167,341 62,441
2025-03-31 $95,565 67,777
2024-12-31 $83,245 41,832
2024-09-30 $94,493 29,998
2024-06-30 $81,224 25,704
2022-09-30 $964 200
2022-06-30 $1,590 200
2022-03-31 $2,938 200
2021-12-31 $4,040 200
2021-09-30 $14,476 533
2021-06-30 $19,480 800
2021-03-31 $53,702 2,200